Peter Forsberg, MD
Assistant Professor, Medicine-Hematology

Photo
Medical School:
  • MD, University of Colorado Denver School of Medicine (2009)
Undergraduate School:
  • BA, Washington University in Saint Louis (MO) (2004)
Residencies:
  • Memorial Sloan-Kettering Cancer Center Program, Chief Resident, Internal Medicine (2013)
  • New York Presbyterian Hospital (Cornell Campus) Program, Internal Medicine (2012)
Fellowships:
  • New York Presbyterian Hospital (Cornell Campus) Program, Cancer / Oncology (2016)
Department: Medicine-Hematology

Research Interests

Dr. Forsberg’s research is focused on developing novel strategies to treat plasma cell disorders including multiple myeloma. He works in collaboration with a group of clinical and laboratory based researchers to better characterize the biology of plasma cell diseases, understand the heterogeneity of these disorders in individual patients and develop personalized approaches to therapy in myeloma and related diseases. He is working to identify new therapeutic targets in multiple myeloma and to identify biomarkers to predict patient responses to different treatments. He is also interested in evaluating and finding approaches to improve the quality of life in patients dealing with a group of diseases whose therapeutic landscape has evolved rapidly in the past several years.

Publications

  • Walker ZJ, Idler BM, Davis LN, Stevens BM, VanWyngarden MJ, Ohlstrom D, Bearrows SC, Hammes A, Smith CA, Jordan CT, Mark TM, Forsberg PA, Sherbenou DW. Exploiting Protein Translation Dependence in Multiple Myeloma with Omacetaxine-Based Therapy. Clin Cancer Res. 2021 Feb 1;27(3):819-830. PubMed PMID: 33109736
  • Walker ZJ, VanWyngarden MJ, Stevens BM, Abbott D, Hammes A, Langouët-Astrie C, Smith CA, Palmer BE, Forsberg PA, Mark TM, Jordan CT, Sherbenou DW. Measurement of ex vivo resistance to proteasome inhibitors, IMiDs, and daratumumab during multiple myeloma progression. Blood Adv. 2020 Apr 28;4(8):1628-1639. PubMed PMID: 32311014
  • Sharma P, Purev E, Haverkos B, Pollyea DA, Cherry E, Kamdar M, Mark T, Forsberg P, Sherbenou D, Hammes A, Rabinovitch R, Smith CA, Gutman JA. Adult cord blood transplant results in comparable overall survival and improved GRFS vs matched related transplant. Blood Adv. 2020 May 26;4(10):2227-2235. PubMed PMID: 32442301
  • Mark TM, Forsberg PA, Rossi AC, Pearse RN, Pekle KA, Perry A, Boyer A, Tegnestam L, Jayabalan D, Coleman M, Niesvizky R. Phase 2 study of clarithromycin, pomalidomide, and dexamethasone in relapsed or refractory multiple myeloma. Blood Adv. 2019 Feb 26;3(4):603-611. PubMed PMID: 30792190
  • Forsberg PA, Rossi AC, Boyer A, Tegnestam L, Pearse RN, Perry A, Pekle KA, Jayabalan D, Ely S, Boussi L, Sherbenou DW, Williams C, Allan JN, Coleman M, Niesvizky R, Mark TM. Phase II study of carfilzomib and dexamethasone therapy for newly diagnosed multiple myeloma. Am J Hematol. 2019 May;94(5):539-545. PubMed PMID: 30740766
  • Forsberg PA, Hammes A, Abbott D, Sherbenou DW, Rossi A, Jayabalan D, Niesvizky R, Mark TM, Ely S. Cellular proliferation by multiplex immunohistochemistry identifies aggressive disease behavior in relapsed multiple myeloma. Leuk Lymphoma. 2019 Aug;60(8):2085-2087. PubMed PMID: 30632821
  • Ely S, Forsberg P, Ouansafi I, Rossi A, Modin A, Pearse R, Pekle K, Perry A, Coleman M, Jayabalan D, Di Liberto M, Chen-Kiang S, Niesvizky R, Mark TM. Cellular Proliferation by Multiplex Immunohistochemistry Identifies High-Risk Multiple Myeloma in Newly Diagnosed, Treatment-Naive Patients. Clin Lymphoma Myeloma Leuk. 2017 Dec;17(12):825-833. PubMed PMID: 29051077
  • Sherbenou DW, Mark TM, Forsberg P. Monoclonal Antibodies in Multiple Myeloma: A New Wave of the Future. Clin Lymphoma Myeloma Leuk. 2017 Sep;17(9):545-554. PubMed PMID: 28734795
  • Mark TM, Guarneri D, Forsberg P, Rossi A, Pearse R, Perry A, Pekle K, Tegnestam L, Greenberg J, Shore T, Gergis U, Mayer S, Van Besien K, Ely S, Jayabalan D, Sherbenou D, Coleman M, Niesvizky R. A Phase I Trial of High-Dose Lenalidomide and Melphalan as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Multiple Myeloma. Biol Blood Marrow Transplant. 2017 Jun;23(6):930-937. PubMed PMID: 28285081
View All (9 Total) View Less

Practice Locations

UCHealth Blood Disorders and Cell Therapies Center - Anschutz Medical Campus
1665 Aurora Court
3rd floor, Anschutz Cancer Pavilion
Aurora, CO 80045
720-848-6400

UCH - Anschutz Inpatient Pavilion
12605 E. 16th Ave
Aurora, CO 80045
720-848-0000

Hospital Affiliation
  • University of Colorado Hospital
Center Affiliations

Specialty Information

Specialties
  • Hematology and Oncology, Board Certification
  • Internal Medicine, Board Certification
Personal Interests
Dr. Forsberg received his bachelor’s degree from Washington University in St. Louis. He completed medical school at the University of Colorado School of Medicine. He went to New York for his medical training and completed his residency in Internal Medicine at the Weill-Cornell Medical College/New York-Presbyterian Hospital. He served as chief medical resident at Memorial Sloan Kettering Cancer Center before returning to Cornell for his fellowship training in Hematology and Medical Oncology. In 2016 he returned to Colorado to join the blood cancer and BMT program at the University of Colorado. Dr. Forsberg’s clinical and research focus centers on multiple myeloma and related diseases including amyloidosis and Waldenstrom’s Macroglobulinemia. He serves as the principle investigator on various clinical trials. He has published and presented his work at the national and international level.

General Information

Medical Schools:
  • MD, University of Colorado Denver School of Medicine (2009)
Undergraduate Schools:
  • BA, Washington University in Saint Louis (MO) (2004)
Residency Programs:
  • Memorial Sloan-Kettering Cancer Center Program, Chief Resident, Internal Medicine (2013)
  • New York Presbyterian Hospital (Cornell Campus) Program, Internal Medicine (2012)
Fellowships:
  • New York Presbyterian Hospital (Cornell Campus) Program, Cancer / Oncology (2016)
Department: Medicine-Hematology
;